{"id":"https://openalex.org/W7221546837","doi":"https://doi.org/10.64898/2026.10.10.26365218","title":"A Distinct Delayed-Onset Intraocular Inflammation Phenotype of Faricimab versus Aflibercept and Ranibizumab: Triangulated Pharmacovigilance Evidence from Databases of US, Europe and Japan","display_name":"A Distinct Delayed-Onset Intraocular Inflammation Phenotype of Faricimab versus Aflibercept and Ranibizumab: Triangulated Pharmacovigilance Evidence from Databases of US, Europe and Japan","publication_year":2026,"publication_date":"2026-10-12","ids":{"openalex":"https://openalex.org/W7221546837","doi":"https://doi.org/10.64898/2026.10.10.26365218"},"language":"en","primary_location":{"id":"doi:10.64898/2026.10.10.26365218","doi":"https://doi.org/10.64898/2026.10.10.26365218","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.10.26365218","pdf_url":null,"source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.64898/2026.10.10.26365218","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5133104124","display_name":"Junhong Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I116953780","display_name":"Tongji University","ror":"https://ror.org/03rc6as71","country_code":"CN","type":"education","lineage":["https://openalex.org/I116953780"]},{"id":"https://openalex.org/I4210092517","display_name":"Shanghai Eye Disease Prevention & Treatment Center","ror":"https://ror.org/0048a4976","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210092517"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Junhong Jiang","raw_affiliation_strings":["Department of Ophthalmology, Shanghai Eye Diseases Prevention & Treatment Center / Shanghai Eye Hospital, Tongji University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, 200041, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Shanghai Eye Diseases Prevention & Treatment Center / Shanghai Eye Hospital, Tongji University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, 200041, China","institution_ids":["https://openalex.org/I116953780","https://openalex.org/I4210092517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112426726","display_name":"Gu Yifan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24943067","display_name":"Fudan University","ror":"https://ror.org/013q1eq08","country_code":"CN","type":"education","lineage":["https://openalex.org/I24943067"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yifan Gu","raw_affiliation_strings":["Department of Ophthalmology, Minhang Hospital, Fudan University, Shanghai 201100, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Minhang Hospital, Fudan University, Shanghai 201100, China","institution_ids":["https://openalex.org/I24943067"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100670615","display_name":"Di Hu","orcid":"https://orcid.org/0000-0002-9411-3246","observed_orcids":["https://orcid.org/0000-0002-9411-3246"]},"institutions":[{"id":"https://openalex.org/I4210159329","display_name":"Children's Hospital of Fudan University","ror":"https://ror.org/05n13be63","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210159329"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Di Hu","raw_affiliation_strings":["Department of Ophthalmology, Children\u2019s Hospital of Fudan University, No.399 Wanyuan Road, Shanghai, 201102, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Children\u2019s Hospital of Fudan University, No.399 Wanyuan Road, Shanghai, 201102, China","institution_ids":["https://openalex.org/I4210159329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5150940788","display_name":"Xinsheng Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122818","display_name":"The Affiliated Taizhou People's Hospital of Nanjing Medical University","ror":"https://ror.org/02fvevm64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210122818"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xinsheng Li","raw_affiliation_strings":["Department of Ophthalmology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, 225300, Jiangsu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, 225300, Jiangsu, China","institution_ids":["https://openalex.org/I4210122818","https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019008782","display_name":"Shiyue Qin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122818","display_name":"The Affiliated Taizhou People's Hospital of Nanjing Medical University","ror":"https://ror.org/02fvevm64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210122818"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shiyue Qin","raw_affiliation_strings":["Department of Ophthalmology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, 225300, Jiangsu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, 225300, Jiangsu, China","institution_ids":["https://openalex.org/I4210122818","https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054517902","display_name":"Qui Ling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122818","display_name":"The Affiliated Taizhou People's Hospital of Nanjing Medical University","ror":"https://ror.org/02fvevm64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210122818"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qipeng Ling","raw_affiliation_strings":["Department of Ophthalmology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, 225300, Jiangsu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, 225300, Jiangsu, China","institution_ids":["https://openalex.org/I4210122818","https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158480392","display_name":"Qi Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122818","display_name":"The Affiliated Taizhou People's Hospital of Nanjing Medical University","ror":"https://ror.org/02fvevm64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210122818"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qi Zhang","raw_affiliation_strings":["Department of Neurology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, 225300, Jiangsu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, 225300, Jiangsu, China","institution_ids":["https://openalex.org/I4210122818","https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158491975","display_name":"Lili Dong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122818","display_name":"The Affiliated Taizhou People's Hospital of Nanjing Medical University","ror":"https://ror.org/02fvevm64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210122818"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lili Dong","raw_affiliation_strings":["Department of Ophthalmology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, 225300, Jiangsu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, 225300, Jiangsu, China","institution_ids":["https://openalex.org/I4210122818","https://openalex.org/I83519826"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089552125","display_name":"Zenan Lin","orcid":"https://orcid.org/0000-0001-5501-6657","observed_orcids":["https://orcid.org/0000-0001-5501-6657"]},"institutions":[{"id":"https://openalex.org/I4210122818","display_name":"The Affiliated Taizhou People's Hospital of Nanjing Medical University","ror":"https://ror.org/02fvevm64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210122818"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zenan Lin","raw_affiliation_strings":["Department of Ophthalmology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, 225300, Jiangsu, China"],"raw_orcid":"https://orcid.org/0000-0001-5501-6657","affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, 225300, Jiangsu, China","institution_ids":["https://openalex.org/I4210122818","https://openalex.org/I83519826"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.01549999974668026,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.01489999983459711,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/faricimab","display_name":"faricimab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/aflibercept","display_name":"aflibercept","score":0.953000009059906},{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":1.0},{"id":"https://openalex.org/keywords/intraocular-inflammation","display_name":"intraocular inflammation","score":0.9649999737739563},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.4779999852180481},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.7609999775886536},{"id":"https://openalex.org/keywords/iridocyclitis","display_name":"iridocyclitis","score":0.7950000166893005},{"id":"https://openalex.org/keywords/uveitis","display_name":"uveitis","score":0.996999979019165},{"id":"https://openalex.org/keywords/endophthalmitis","display_name":"endophthalmitis","score":0.8600000143051147},{"id":"https://openalex.org/keywords/vitreous-hemorrhage","display_name":"vitreous hemorrhage","score":0.8799999952316284},{"id":"https://openalex.org/keywords/time-to-onset","display_name":"time to onset","score":0.5960000157356262},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.777999997138977},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4099999964237213},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.6150000095367432},{"id":"https://openalex.org/keywords/reporting-odds-ratio","display_name":"reporting odds ratio","score":0.5989999771118164},{"id":"https://openalex.org/keywords/weibull-distribution","display_name":"Weibull distribution","score":0.578000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8508999943733215},{"id":"https://openalex.org/C2778749236","wikidata":"https://www.wikidata.org/wiki/Q4689286","display_name":"Aflibercept","level":4,"score":0.7828999757766724},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.5164999961853027},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5041000247001648},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46369999647140503},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.43810001015663147},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.42410001158714294},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.3978999853134155},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.32280001044273376},{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.2955000102519989},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2906999886035919},{"id":"https://openalex.org/C2776215756","wikidata":"https://www.wikidata.org/wiki/Q412909","display_name":"Certolizumab pegol","level":4,"score":0.2757999897003174},{"id":"https://openalex.org/C2776194053","wikidata":"https://www.wikidata.org/wiki/Q280027","display_name":"Uveitis","level":2,"score":0.27390000224113464},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.2712000012397766},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2621000111103058},{"id":"https://openalex.org/C2776740260","wikidata":"https://www.wikidata.org/wiki/Q634959","display_name":"Latanoprost","level":3,"score":0.2612999975681305},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.25769999623298645},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.25609999895095825},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.2547999918460846},{"id":"https://openalex.org/C2780276452","wikidata":"https://www.wikidata.org/wiki/Q2193376","display_name":"Travoprost","level":4,"score":0.2531000077724457},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.2524000108242035},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2517000138759613}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.10.10.26365218","doi":"https://doi.org/10.64898/2026.10.10.26365218","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.10.26365218","pdf_url":null,"source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.10.10.26365218","doi":"https://doi.org/10.64898/2026.10.10.26365218","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.10.26365218","pdf_url":null,"source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1988100739","https://openalex.org/W2004117352","https://openalex.org/W2005366883","https://openalex.org/W2015487160","https://openalex.org/W2064716383","https://openalex.org/W2091989599","https://openalex.org/W2124415048","https://openalex.org/W2132404683","https://openalex.org/W2160226180","https://openalex.org/W2233259956","https://openalex.org/W2792151316","https://openalex.org/W2988706549","https://openalex.org/W2995674745","https://openalex.org/W3017504588","https://openalex.org/W3110220146","https://openalex.org/W3194753000","https://openalex.org/W3194796682","https://openalex.org/W4207026636","https://openalex.org/W4252511080","https://openalex.org/W4283031288","https://openalex.org/W4386810021","https://openalex.org/W4391930651","https://openalex.org/W4392297788","https://openalex.org/W4396696202","https://openalex.org/W4400612693","https://openalex.org/W4401480215","https://openalex.org/W4406738601","https://openalex.org/W4407122100","https://openalex.org/W4408379116","https://openalex.org/W4409391283","https://openalex.org/W4409994598","https://openalex.org/W4411094639","https://openalex.org/W7130590596","https://openalex.org/W7161753603","https://openalex.org/W7162642381","https://openalex.org/W7164050546","https://openalex.org/W7204855633"],"related_works":["https://openalex.org/W4415899526","https://openalex.org/W4406343021","https://openalex.org/W7161400306","https://openalex.org/W7136635588","https://openalex.org/W4392297788","https://openalex.org/W4406109881","https://openalex.org/W4403298833","https://openalex.org/W7125712433","https://openalex.org/W4413113217","https://openalex.org/W7124849201"],"abstract_inverted_index":{"Abstract":[0],"Purpose":[1],"Post-marketing":[2],"reports":[3,51],"have":[4],"associated":[5],"faricimab,":[6,110],"the":[7,303],"first":[8],"intravitreal":[9],"bispecific":[10],"antibody,":[11],"with":[12,34,55,77,91,97,184,292],"intraocular":[13,199,278],"inflammation":[14,279,289],"(IOI).":[15],"Its":[16],"inflammatory":[17],"phenotype,":[18],"temporal":[19],"pattern,":[20],"and":[21,36,61,66,94,113,123,143,150,153,198,218,233,276,282,310,323],"systemic":[22,253],"safety":[23,254],"relative":[24],"to":[25,68,265],"established":[26],"anti-VEGF":[27],"agents":[28],"remain":[29],"unclear.":[30],"We":[31,48],"compared":[32],"faricimab":[33,134],"aflibercept":[35,281],"ranibizumab":[37,115,202,283,311],"across":[38,213,284],"three":[39,285],"independent":[40,286],"pharmacovigilance":[41],"databases.":[42,287],"Design":[43],"Triangulated":[44],"Pharmacovigilance":[45],"study.":[46],"Methods":[47],"analyzed":[49],"FAERS":[50,106],"(Q1":[52],"2022-Q2":[53],"2026)":[54],"external":[56],"validation":[57],"in":[58,166,207,223,236],"JADER":[59,167,238],"(Japan)":[60],"EudraVigilance":[62],"(Europe).":[63],"After":[64],"de-duplication":[65],"restriction":[67],"primary-suspect":[69],"reports,":[70],"we":[71],"computed":[72],"reporting":[73,120,212,273,320],"odds":[74],"ratios":[75],"(RORs)":[76],"false":[78],"discovery":[79],"rate":[80],"control,":[81],"derived":[82],"confounder-adjusted":[83],"RORs":[84,127],"by":[85],"logistic":[86],"regression,":[87],"modeled":[88],"time-to-onset":[89],"(TTO)":[90],"Weibull":[92,188],"distributions,":[93],"graded":[95],"signals":[96],"a":[98,185,243,250,293],"pre-specified":[99],"bidirectional":[100],"cross-database":[101],"evidence":[102],"framework.":[103],"Results":[104],"The":[105],"cohort":[107],"comprised":[108],"6,833":[109],"6,714":[111],"aflibercept,":[112,149],"2,533":[114],"reports.":[116],"Faricimab":[117,171,209,241,270],"showed":[118,210,271,317],"higher":[119,272],"of":[121,274,296],"anterior-chamber":[122],"vitreal":[124],"inflammation:":[125],"adjusted":[126],"(comparator":[128],"versus":[129,148,156,299],"faricimab;":[130],"values":[131],"<1":[132],"indicate":[133],"excess)":[135],"were":[136,164],"0.27":[137],"(95%":[138],"CI":[139],"0.18-0.40)":[140],"for":[141,146,196,203,302,307,312],"iridocyclitis":[142],"0.45":[144],"(0.35-0.58)":[145],"uveitis":[147],"0.13":[151],"(0.06-0.24)":[152],"0.12":[154],"(0.06-0.20)":[155],"ranibizumab.":[157],"All":[158],"four":[159],"core":[160],"IOI":[161,172,247,261],"preferred":[162],"terms":[163],"Confirmed":[165],"against":[168],"both":[169],"comparators.":[170,304],"arose":[173,290],"late":[174],"(median":[175],"TTO":[176],"100":[177,297],"vs":[178,192],"7":[179,300],"days;":[180],"P":[181],"=":[182],"2.6E-14)":[183],"markedly":[186],"flatter":[187],"distribution":[189],"(shape":[190],"0.81":[191],"\u22480.42).":[193],"Aflibercept":[194,305],"predominated":[195,306],"endophthalmitis-spectrum":[197,308],"pressure":[200],"events;":[201],"vitreous":[204,313],"hemorrhage":[205],"(confirmed":[206],"JADER).":[208],"lower":[211],"cardiac,":[214],"nervous":[215],"system,":[216],"vascular,":[217],"renal":[219],"organ":[220],"classes,":[221],"confirmed":[222],"EudraVigilance.":[224],"An":[225],"unadjusted":[226],"death":[227,319],"signal":[228],"did":[229],"not":[230],"survive":[231],"adjustment":[232,322],"was":[234],"absent":[235],"outcome-based":[237],"analyses.":[239],"Conclusions":[240],"exhibits":[242],"reproducible,":[244],"delayed-onset,":[245],"anterior-predominant":[246],"phenotype":[248],"alongside":[249],"comparatively":[251],"favorable":[252],"profile.":[255],"Clinicians":[256],"should":[257],"recognize":[258],"that":[259],"faricimab-associated":[260],"may":[262],"arise":[263],"weeks":[264],"months":[266],"after":[267,321],"injection.":[268],"Highlights":[269],"anterior":[275],"intermediate":[277],"than":[280],"Faricimab-associated":[288],"late,":[291],"median":[294],"onset":[295],"days":[298,301],"events":[309],"haemorrhage.":[314],"No":[315],"drug":[316],"excess":[318],"outcome-field":[324],"verification.":[325]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-10-13T00:00:00"}